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Effect of melphalan and hyperthermia on p34cdc2 kinase activity in human
melanoma cells
L Orlandi, N Zaffaroni, A Bearzatto and R Silvestrini
Divisione di Oncologia Sperimentale C, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Summary We previously reported that combined treatment with melphalan and mild hyperthermia (1 h at
42°C) caused a synergistic cytotoxic effect in JR8 melanoma cells, paralleled by a stabilisation of a melphalan-
induced G2-phase cell block. In this study, we investigated the effect of melphalan and hyperthermia on
proteins that regulate G2-M transition. Neither hyperthermia nor melphalan at a concentration of
2.5 ,ug ml-, which had no antiproliferative effect at 37°C, interfered with cyclin B1 expression or p34cdc2
kinase activity. At a concentration of 8.5 Mg ml -, which reduced cell growth by 50% at 37°C, melphalan
inhibited p34cdc2 kinase activity as a consequence of an increased tyrosine phosphorylation of the protein. A
similar inhibitory effect on p34c2 kinase was obtained when the lowest melphalan concentration (2.5 ig ml- )
was used under hyperthermic conditions. Our results indicate that thermal enhancement of melphalan
cytotoxicity could be mediated at least in part by an inhibition of p34XCd2 kinase activity, which prevents cell
progression into mitosis.
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Clinical studies on melanoma (Santinami et al., 1989) have
shown that hyperthermia increases the anti-tumour activity of
some bifunctional alkylating agents such as L-phenylalanine
mustard (melphalan, L-PAM). The mechanisms responsible
for the thermal enhancement of L-PAM activity are not yet
completely understood. In experimental systems (1) an
increase in L-PAM influx leads to a higher intracellular
drug accumulation (Bates and MacKillop, 1989), (2)
alteration of the DNA quaternary structure, which favours
alkylation (Mills and Meyn, 1981), (3) interference with
drug-DNA adduct metabolism (Zaffaroni et al., 1992) and
(4) inhibition of DNA repair (Jorritsma et al., 1985) have
been demonstrated. Moreover, we recently showed that
hyperthermia can stabilise the transient accumulation of
cells in G2-phase induced by L-PAM in human melanoma
cells (Orlandi et al., 1995).
Considerable progress has been made in understanding the
proteins which regulate cell cycle progression. Specifically, the
primary participants in G2 M transition are a cyclin-
dependent kinase, p34 Ic2 and the cyclin B protein, which
regulates the activity of the kinase (Lewin, 1990; Nurse, 1990;
Solomon et al., 1990). Here, we investigated the effect exerted
by L-PAM, under normothermic and hyperthermic condi-
tions, on the expression of cyclin B1 protein as well as on the
catalytic activity of p34cdc2 kinase in a human melanoma cell
line.
Materials and methods
Cell line
The human melanoma cell line JR8 (Zupi et al., 1985) was
grown at 37°C in a 5% carbon dioxide humidified atmo-
sphere in air, with RPMI-1640 medium (Bio Whittaker,
Verviers, Belgium), containing 10% fetal calf serum
(Biological Industries, Kibbutz Beth Haemek, Israel), 2 mM
L-glutamine and gentamycin (0.1 mg ml-'). During the phase
of exponential growth, JR8 cells have a doubling time of
about 24 h. All experiments were performed within the tenth
passage after thawing.
Heat and drug treatments
Cells were exposed to heat by placing T-25 flasks in a
controlled precision water bath at 42°C (+0.05°C) for 1 h.
For treatment with L-PAM (Sigma, St Louis, MO, USA) in
normothermic or hyperthermic conditions, cells were exposed
for 1 h to different drug concentrations or to the drug solvent
(control samples). The temperature and exposure times were
chosen because they correspond to the treatment perfusion in
melanoma patients (Vaglini et al., 1986; Ghussen et al., 1988).
Following treatment with hyperthermia, L-PAM, or both,
cells were rinsed with phosphate-buffered saline (PBS) and
fed with fresh medium. Each experimental point was run in
triplicate. Experiments were repeated three times. Treatment-
induced cytotoxicity was determined with a 96 h growth
inhibition assay by using an electronic cell counter (Coulter
Electronics, Hialeah, FL, USA) as previously described
(Orlandi et al., 1995). Results were expressed as the cell
number of treated samples compared with control samples.
Bivariateflow cytometric analysis of DNA content/cyclin B,
expression
At different intervals after treatment, cells were fixed in
acetone and absolute ethanol (1:1) for 30 min at -20°C, then
centrifuged and washed with 70% ethanol and PBS. The cells
were incubated overnight with the monoclonal antibody to
human cyclin B1 (PharMingen, San Diego, CA, USA) at a
dilution of 1:400 in PBS containing 1% bovine serum albumin
(BSA), then washed and incubated with FITC-conjugated
goat anti-mouse IgG antibody (Sigma) diluted 1:40 in PBS
containing 1% BSA. The cells were resuspended in 10 ,ug ml-'
propidium iodide and 0.1% RNAase in PBS and incubated at
room temperature for 30 min in the dark (Gong et al., 1993).
The fluorescence of stained cells was measured using a
FACScan flow cytometer (Becton Dickenson, San Jose, CA,
USA). Data were acquired and processed with Lysis II
software (Becton Dickinson). A minimum of 104 cells was
measured for each sample. The percentage ofcells in the G2M
cell phase was evaluated by the Cell Fit software according to
the SOBR model (Becton Dickinson).
Immunoblotting
At 48 and 72 h after treatment, cells were lysed on ice with a
RIPA buffer (20 mM Tris pH 7.4, 150 mM sodium chloride,
Correspondence: R Silvestrini
Received 4 April 1996; revised 3 July 1996; accepted 8 July 1996-Inhibition of p34cdc2 kinase activity by L-PAM and hyperthermia
L Orlandi et al
5 mM EDTA, 1% NP40, 50 mM sodium fluoride and
protease inhibitors aprotinin, leupeptin, pepstatin at a
concentration of 10 jug ml-', and 2 mM phenylmethylsulpho-
nylfluoride). Each lysate was centrifuged at 15 000 g for
20 min, and the protein content of each supernatant was
quantified by the Bio-Rad protein assay. Total cellular
protein (50 ,ug) boiled in 2 x sodium dodecyl sulphate
(SDS) gel loading buffer (250 mM Tris pH 6.8, 2% SDS, 30%
glycerol, 10% 2-mercaptoethanol and 0.01% bromophenol
blue) was separated on 12% SDS-polyacrylamide gel and
transferred to nitrocellulose. Filters were blocked overnight in
TBS-T buffer (20 mM Tris, 137 mM sodium chloride, pH 7.6,
0.1% Tween 20) with 5% skim milk and then incubated with
the primary monoclonal antibody anti-p34cdc2 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Unbound antibody
was removed and filters were then incubated with the
secondary antibody anti-mouse Ig horseradish peroxidase-
linked whole antibody (Amersham, Bucks, UK). Bound
antibody was detected using the enhanced chemilumines-
cence Western blotting detection system (Amersham). To
reprobe with alternative antisera, the membranes were
immersed in a stripping solution (100 mM 2-mercaptoetha-
nol, 2% SDS, 62.5 mM Tris, pH 6.7) for 30 min at 50°C.
Non-specific binding sites were blocked in 5% skim milk/
TBS-T and the filter reprobed with anti-phosphotyrosine
(Boehringer Mannheim, Mannheim, Germany) as primary
antibody.
Immunoprecipitation and histone H, kinase assay
Total cellular protein (100 pjg), obtained by lysing cells with
RIPA buffer as described before, was immunoprecipitated by
anti-p34cdc2 agarose conjugate (Santa Cruz Biotechnology) for
4 h at 4°C. Immunoprecipitates were then washed four times
with RIPA buffer and resuspended in 50 pl of kinase buffer
containing 50 mM Tris, pH 7.4, 10 mM magnesium chloride,
1 mM dithiothreitol and 50 jg ml-' histone H, (Boehringer
Mannheim). Following a preincubation of 10 min at 30°C,
reactions were started by the addition of 10 ,iCi of [y-32P]ATP
(specific activity 3000 Ci mmol-1), incubated at 30°C for
20 min, and stopped by the addition of 50 kl of 2 x SDS gel
loading buffer. The mixtures were denatured at 95°C for
5 min and separated on 12% SDS-polyacrylamide gel. Bands
were detected by autoradiography and quantified by an
Ultrascan XL enhanced laser densitometer (LKB, Turku,
Finland).
Table I G2M cell fraction and cyclin B1-expressing cells at different
intervals after treatment
Control L-PAM 37°C Control L-PAM
42°C
(37°C) 2.5ugml-18.5pgml-' (42°C) 2.5,igml-'
Oh
G2M 12+3 15+2 13+4 15+3 17+4
Cyclin B1 18+4 18+4 20+5 18+2 20+7
24h
G2M 13+6 13+4 13+2 14+5 15+5
Cyclin B1 19+5 23+5 24+4 18+6 26+8
48 h
G2M 15+3 24+5 27+4a 12+5 34+3a
Cyclin B1 17+4 29+7 35+3a 19+3 40+4a
72h
G2M 13+2 15+4 62+5a 10+4 59+5a
Cyclin B, 18+4 22+3 60+7a 16+3 63+Sa
96h
G2M 10+5 11 +6 33+5a 9+4 43+4a
Cyclin B1 11+3 15+7 35+7a 13+5 45+7a
Data represent mean values+s.d. from three independent experi-
ments. ap <0.05, Student's t-test, compared with control at 37°C.
Results
Effect ofhyperthermia and/or L-PAM on tumour cell growth
A 1 h exposure to 42°C did not induce any appreciable effect
in JR8 cell growth at 96 h after treatment. Specifically, a very
modest inhibition (- 5%) was observed in the cell number of
heat-treated cells as compared with controls. In normother-
mic conditions, a 1 h exposure to L-PAM produced a
negligible decrease (-6%) in cell proliferation at the lowest
concentration of 2.5 jug ml-'. The growth inhibitory effect
was considerably higher (-50%) when cells were exposed to
the highest drug concentration of 8.5 jug ml-'. A similar
antiproliferative effect (-46%) was reached after combined
treatment with 2.5 ,ug ml-1 L-PAM under hyperthermic
conditions.
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Figure 1 Variation in the percentage of G2M cells (a) and cyclin
B1-expressing cells (b) at different intervals after a 1 h exposure to
L-PAM and/or hyperthermia. Results were obtained by bivariate
flow cytometric analysis of DNA content/cyclin B, expression, as
described in Materials and methods. Control cells maintained at
37°C without any treatment (0 0); cells exposed to 42°C
(O- - - 0), 2.5Mgml L-PAM at 370C (0 *), 8.Spgml l L-
PAM at 37°C (l *) and 2.5pgml 1 L-PAM at 420C
(-- -0)
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Effect of hyperthermia and/or L-PAM on G2M cellfraction
and cyclin B, expression
Hyperthermia did not induce any variation in the G2M cell
fraction (Table I and Figure la). Exposure to the lowest L-
PAM concentration (2.5 pg ml-') produced a slight and
temporary increase in the G2M cell fraction, appreciable only
at 48 h. Following exposure to the highest L-PAM
concentration (8.5 pg ml-'), a persistent block of cells in
the G2M-phase was observed. Such an accumulation was
maximum at 72 h and, although to a lesser extent, still
appreciable at 96 h. A comparable persistent G2M accumula-
tion was obtained after treatment of cells with 2.5 pg ml-'
under hyperthermic conditions. Such G2M accumulations
were primarily caused by a block of cells in the G2-phase,
since the mitotic cells never accounted for more than 2% of
the overall cell population (data not shown).
The fraction of cyclin B,-expressing cells, determined by
flow cytometry on the same cell samples, was similar to the
fraction of G2M-phase cells in control samples as well as in
samples treated with L-PAM, hyperthermia, or both (Table I
and Figure lb).
Effect ofhyperthermia and/or L-PAM on the catalytic activity
ofp34cdc2 kinase
At 48 h and 72 h after treatment, the JR8 cell extract was
immunoprecipitated by using anti-p34 lc2 antibody and the
kinase activity measured by using histone H, as a substrate
(Figure 2). Immunoprecipitates obtained from cells treated
with hyperthermia or with 2.5 pg ml-' L-PAM phosphory-
lated histone H, to a similar degree as in control cells (Table
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Figure 2 A representative experiment illustrating the effect of a
1 h exposure to L-PAM and/or hyperthermia on the catalytic
activity of p34cdc2 kinase in the JR8 cell line. An aliquot of 100 pg
of total cell proteins obtained from cells 48 h and 72h after
treatment was immunoprecipitated with anti-p34cdc2 monoclonal
antibody, and histone HI kinase activity of immunoprecipitates
(IP) was analysed as described in Materials and methods. Lane 1,
control cells (maintained at 370C without any treatment); lane 2,
cells treated with 2.5pgml-1 L-PAM at 37°C; lane 3, cells treated
with 8.5 pgml-1 L-PAM at 37'C; lane 4, cells exposed to 42°C;
lane 5, cells treated with 2.5pgml-1 L-PAM at 42°C.
II). Conversely, immunoprecipitates obtained 48 h and 72 h
after treatment with 8.5 pg ml-' L-PAM showed a strongly
decreased kinase activity compared with controls. A similarly
pronounced inhibition of p34cdc2 catalytic activity was seen in
immunoprecipitates obtained from cells exposed to the
combined treatment with 2.5 pg ml-' L-PAM and hyperther-
mia.
Effect ofhyperthermia and/or L-PAM on the expression and
phosphorylation state ofp34cdc2
To investigate whether inhibition of the kinase catalytic
activity was ascribable to a decreased expression of p34' l2,
we examined the protein levels at 48 h and 72 h after
exposure of cells to hyperthermia, L-PAM, or both. No
remarkable difference was observed in the level of p34cdc2
among the different treatment groups (Figure 3, upper panel
and Table II). Since p34cdc2 catalytic activity is known to be
modulated by phosphorylation of its tyrosine and threonine
residues, we also investigated the effect of hyperthermia and
L-PAM, singly or in association, on the phosphorylation state
of p34c"C2. The immunoblots with anti-phosphotyrosine
antibody (Figure 3, lower panel and Table II) showed that
samples treated with hyperthermia alone or with 2.5 pg ml-'
L-PAM exhibited a p34cdc2 tyrosine phosphorylation similar
to that of control samples. Conversely, samples exposed to
8.5 pg ml-' L-PAM showed an increase in the degree of
tyrosine phosphorylation. A similarly pronounced increase
was observed in samples exposed to the combined treatment
with 2.5 pg ml-' L-PAM and hyperthermia.
Discussion
We investigated the effect of hyperthermia and L-PAM on
G2 -M transition in a human melanoma cell line. A 1 h
exposure to 42°C did not affect the growth of JR8 cells. Such
a result is in agreement with previous evidence by our
(Zaffaroni et al., 1992; Orlandi et al., 1993, 1995) and other
groups (Rofstad et al., 1990), indicating a negligible effect of
mild hyperthermia itself on human melanoma-established cell
lines and primary cultures. Moreover, clinically mild
hyperthermia is devoid of any significant anti-tumour effect,
and it is generally used in conjunction with alkylating agents
to modulate drug activity positively in drug-refractory
tumours, such as melanoma (Santinami et al., 1989; Ghussen
et al., 1988). In JR8 cells, hyperthermia markedly increased
the cytotoxic effect of a low L-PAM concentration and
stabilised the transient L-PAM-induced G2 accumulation.
Under normothermic conditions, such a low L-PAM
concentration only induced a negligible inhibitory effect on
cell growth and a modest increase in G2 cell fraction,
Table II Densitometric analysis of the immunoblotting or histone H, kinase activity
37°C 420C
L-PAM L-PAM
Control 2.5pgml-' 8.5pgml-' Control 2.5pgml-'
At 48h
Immunoblotting
p34cdc2 1.00 0.93+0.15 1.13+0.11 0.95+0.13 1.10+0.11
Phosphotyrosine 1.00 0.96+0.13 1.30+0.14 0.89+0.10 1.45+0.18a
Kinase activity 1.00 1.15 +0.13 0.35+0.1Sa 0.95+0.07 0.17+0.07a
At 72 h
Immunoblotting
p34cdc2 0.91 +0.28 0.82+0.25 0.92+0.20 0.89+0.14
Phosphotyrosine 0.95 +0.14 1.37+0.12 0.96+0.15 1.34+0.21
Kinase activity 1.07+0.21 0.28 +0.1Oa 0.94+0.08 0.19+0.08a
The relative intensity of the bands of the immunoblot analysis performed with anti-p34cdc2 or anti-
phosphotyrosine monoclonal antibodies and ofkinase assay are reported. Exent ofthe signal was quantified by
using an ultrascan XL densitometer. Data are shown as the ratio to the control at 37°C and represent mean
values +s.d. from three independent experiments. ap<0.05, Student's t-test, compared with control at 37°C.Inhibition of p34cdc2 kinase activity by L-PAM and hyperthermia
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Figure 3 A representative experiment illustrating the effect of a
1 h exposure to L-PAM and/or hyperthermia on the expression
and phosphorylation state of p34cdc2 kinase in the JR8 cell line.
Cells were harvested at 48h and 72h after treatment and
processed by immunoblot analysis. Whole cell extract (50jg)
was separated and electrophoretically blotted. Proteins were
probed with anti-p34c2 (upper panel) and reprobed, after filter
stripping, with anti-phosphotyrosine (lower panel). Lane 1,
control cells (maintained at 37°C without any treatment); lane
2, cells treated with 2.5pgmI-1 L-PAM at 37°C; lane 3, cells
treated with 8.5jigmV-1 L-PAM at 37°C; lane 4, cells exposed to
42°C; lane 5, cells treated with 2.5jigml-l L-PAM at 42°C.
appreciable 48 h after treatment. Cytotoxic effects and cell
cycle perturbations comparable to those produced by
combined treatment were obtained with L-PAM under
normothermic conditions using a more than 3-fold drug
concentration.
The mechanism by which hyperthermia can prolong the
G2 cell block induced by L-PAM has not yet been
investigated. In DNA lesions, L-PAM produces interstrand
cross-links, which may arrest cells in G2 by preventing strand
segregation. If this were true, it could be that persistence of
G2 accumulation depends on the stability of DNA cross-links
(Konopa, 1988). In a previous study on melanoma primary
cultures, we demonstrated that hyperthermia was able to
increase the accumulation of L-PAM-induced DNA inter-
strand cross-links and to prevent their long-term removal
(Zaffaroni et al., 1992). However, the coupling of DNA
damage to cell cycle perturbation induced by L-PAM is still
largely unclear.
Hyperthermia could also stabilise L-PAM-induced G2
accumulation through an inhibitory effect on proteins that
regulate G2-M transition. Such a transition in eukaryotic
cells is controlled by a mitosis-promoting factor (MPF),
which consists of a regulatory subunit, a specific B-type
cyclin, and the catalytic subunit, p34cdc2 kinase (Lewin, 1990;
Nurse, 1990; Norbury and Nurse, 1992).
Results we obtained from DNA/cyclin B, bivariate flow
cytometric analysis performed on JR8 cells exposed to L-
PAM under normothermic or hyperthermic conditions
indicated that hyperthermia, L-PAM or both did not reduce
the expression of cyclin B,, thus suggesting that this
regulatory protein is not an important target for L-PAM/
hyperthermia-induced cell cycle arrest. Conversely, the
highest concentration of L-PAM, under normothermic
conditions, and the lowest one, in conjunction with
hyperthermia, induced a marked inhibition of p34cdc2 kinase
activity in correspondence with the accumulation of cells in
the G2-phase. Such a negative modulation of p34c c2 kinase
activity was not caused by an alteration in the overall level of
the protein. This finding, together with the evidence that
cyclin B, protein level continued to accumulate after L-PAM/
hyperthermia treatment, suggested that cell cycle delay is not
mediated through a lack of MPF complex formation.
Exposure to the highest L-PAM concentration at 37°C, as
well as to the lowest one at 42°C, enhanced the level of
tyrosine phosphorylation of p34cdc2. Such an effect was more
pronounced after combined L-PAM/hyperthermia treatment.
Since activation of MPF results from the dephosphorylation
of cyclin B-bound p34Cdc2, our findings suggest that a
treatment-induced G2 accumulation results from the inability
to activate MPF. The lack of MPF activity may be due to an
up-regulation of cdc2 tyrosine kinase activity or a down-
regulation of tyrosine phosphatase activity. Recent data
(O'Connor et al., 1992) indicated that inhibition of p34cdc2
kinase activity by another bifunctional alkylating agent,
nitrogen mustard (HN2), on lymphoma cells was consequent
on a down-regulation of the cdc25 tyrosine phosphatase
(O'Connor et al., 1994).
On the whole, our results indicate thermal stabilisation of
cell cycle perturbations induced by L-PAM as one of the
possible mechanisms for the enhancement of L-PAM
cytotoxic activity under hyperthermic conditions. Specifi-
cally, hyperthermia seems to enhance the inhibition of p34cdc2
kinase activity induced by L-PAM as a consequence of an
increased tyrosine phosphorylation of the protein.
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